DK0570352T3 - - Google Patents

Info

Publication number
DK0570352T3
DK0570352T3 DK93870065.5T DK93870065T DK0570352T3 DK 0570352 T3 DK0570352 T3 DK 0570352T3 DK 93870065 T DK93870065 T DK 93870065T DK 0570352 T3 DK0570352 T3 DK 0570352T3
Authority
DK
Denmark
Prior art keywords
platelet aggregation
human
human platelet
novel hexapeptide
neuthrophis
Prior art date
Application number
DK93870065.5T
Other languages
English (en)
Inventor
Steven Paul Adams
Eric Joel Brown
Hattie Darden Gresham
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0570352T3 publication Critical patent/DK0570352T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK93870065.5T 1992-04-09 1993-04-08 DK0570352T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/866,678 US5225531A (en) 1992-04-09 1992-04-09 Hexapeptide Lys Gly Ala Gly Asp Val

Publications (1)

Publication Number Publication Date
DK0570352T3 true DK0570352T3 (da) 1997-02-17

Family

ID=25348153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93870065.5T DK0570352T3 (da) 1992-04-09 1993-04-08

Country Status (7)

Country Link
US (1) US5225531A (da)
EP (1) EP0570352B1 (da)
JP (1) JP3334936B2 (da)
AT (1) ATE142225T1 (da)
CA (1) CA2093753A1 (da)
DE (1) DE69304409T2 (da)
DK (1) DK0570352T3 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG52262A1 (en) * 1993-01-08 1998-09-28 Tanabe Seiyaku Co Peptide inhibitors of cell adhesion
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
JP2002533416A (ja) 1998-12-23 2002-10-08 ジー．ディー．サール ＆ カンパニー 新形成の治療における組み合わせ治療としてのシクロオキシゲナーゼ−２インヒビターおよび一つまたはそれ以上の抗腫瘍薬の使用方法
US6544750B1 (en) * 1999-08-17 2003-04-08 Thromgen, Inc. Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
US20190284259A1 (en) * 2016-07-22 2019-09-19 Georgia State University Research Foundation Monoclonal Antibodies to B Virus And Their Use For Identification Of B Virus Specific Reactive Peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057604A (en) * 1988-08-03 1991-10-15 Washington University Novel monoclonal antibodies

Also Published As

Publication number Publication date
JPH0649095A (ja) 1994-02-22
CA2093753A1 (en) 1993-10-10
JP3334936B2 (ja) 2002-10-15
US5225531A (en) 1993-07-06
EP0570352B1 (en) 1996-09-04
DE69304409D1 (de) 1996-10-10
ATE142225T1 (de) 1996-09-15
EP0570352A1 (en) 1993-11-18
DE69304409T2 (de) 1997-03-20

Similar Documents

Publication Publication Date Title
GR3029874T3 (en) Sulfonylaminopyrimidines, their preparation and their use as medicine.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
DK0530505T3 (da) Hydantoinderivater
EP0648492A3 (en) Inhibition of phosphatidylinositol-3-kinase with viridin, dimethoxyviridin, viridiol, dimethoxyviridiol, virone, wortmannolone, and their derivatives.
GR3026369T3 (en) Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist.
UA26973A1 (uk) Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів
MY131316A (en) Adhesive/mechanical fastener systems for disposable absorbent articles
DK0570352T3 (da)
WO1996022305A3 (en) Modified peptides
HUT70271A (en) Collagen-induced platelet aggregation inhibitor
GR3029489T3 (en) Use of leflunomid for the inhibition of interleukin 8.
EP0693067A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
NZ201895A (en) 2-beta-substituted-2-alpha-methyl-(5r)-penam-3-alpha-carboxylic acid 1,1-dioxides;intermediates and pharmaceutical compositions
EP0711156A4 (en) USE OF N-METHYL ASPARAGIC ACID TO PROMOTE GROWTH AND CHANGE THE BODY COMPOSITION
HU9201117D0 (en) Substituted 2',3'-didezoxy-5-trifluor-methyl-uridine, and process for the production of medical preparations containing such compounds
AU631302B2 (en) Bacteriocin peptide
IL106064A0 (en) Gallium complexes for the treatment of free radicalinduced diseases
GR3035058T3 (en) Use of derivatives of beta-naphthoquinone for inhibiting platelet aggregation.
EP0645138A3 (fr) Composition pharmaceutique visant à maintenir et/ou rétablir un taux d'agrégation des plaquettes sanguines proche de la valeur normale.
ATE155470T1 (de) Cephem verbindungen mit antimicrobizide eigenschaften
GR3029492T3 (en) Use of leflunomid for the inhibition of interleukin 1 alpha.
EP0505901A3 (en) Use of 1-phenoxycarbonyl-2-pyrralidinone derivatives for treating or preventing platelet aggregation
IL108924A0 (en) Compositions for the treatment of eye diseases
MX9603231A (es) Pigmentos de vanadato de bismuto conteniendo hierro.